- Medison Expresses Concerns over Knight Therapeutics’ Second Quarter Results and Demands Answers to Critical Questions from Jonathan Goodman
- MEDISON BIOTECH CONSIDERS REQUISITION OF SPECIAL MEETING OF SHAREHOLDERS OF KNIGHT THERAPEUTICS INC.
- Medison Biotech: Jonathan Goodman takes advantage of his own failure to create value, enriching himself at the expense of the shareholders of Knight Therapeutics
- Medison Issues Open Letter to Knight Therapeutics Shareholders Urging Jonathan Goodman to Build Real Business during the Grace Period Knight Received
- Medison Creates Significant Change at Knight Therapeutics